Chapter
Baseline characteristics second follow-up survey (March–September 2024)
Concepts
- Follow-up Cohort
"The follow-up cohort of 2024 included 568 respondents from the initial cohort. Compared with participants who did not complete Phase II (n = 424), responders were older in Phase I (mean [SD], 46.41 [
- Participant Profile
"The mean (SD) age was 49.4 (13.1) years, and 352 (62%) were female. Since 2021, most participants had received additional SARS-CoV-2 vaccinations, and 449 (79.0%) reported at least one reinfection."
- Concomitant Disorders
"Most frequent concomitant disorders were again allergies 207 (36.4%), hypertension 83 (14.6%), and asthma 49 (8.6%). Detailed demographic, vaccination, and clinical characteristics are shown in Suppl